Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (476)
|
Core Tip (518)
|
Full Article (HTML) (1965)
|
Figures (1-1) (348)
|
Full Article (PDF)-1204K (131)
|
Full Article with Cover (PDF)-11949K (110)
|
Full Article (XML)-236K (75)
|
Audio-1342K (6)
|
Peer-Review Report-230K (76)
|
Answering Reviewers-97K (70)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5393)
|
Similar Articles (75)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (499)
|
Core Tip (540)
|
Full Article (HTML) (1331)
|
Tables (1-1) (426)
|
Full Article (PDF)-358K (116)
|
Full Article with Cover (PDF)-11106K (115)
|
Full Article (XML)-54K (67)
|
Audio-1072K (9)
|
Peer-Review Report-236K (63)
|
Answering Reviewers-62K (62)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4455)
|
Similar Articles (19)
|
Timeline of Article Publication (1)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions

World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (539)
|
Core Tip (454)
|
Full Article (HTML) (4552)
|
Figures (1-2) (372)
|
Tables (1-5) (350)
|
Full Article (PDF)-1655K (203)
|
Full Article with Cover (PDF)-12399K (148)
|
Full Article (XML)-226K (68)
|
Audio-1259K (9)
|
Peer-Review Report-216K (72)
|
Answering Reviewers-145K (68)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (7766)
|
Similar Articles (63)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (540)
|
Core Tip (476)
|
Full Article (HTML) (3094)
|
Figures (1-1) (376)
|
Full Article (PDF)-601K (221)
|
Full Article with Cover (PDF)-11346K (87)
|
Full Article (XML)-89K (77)
|
Audio-384K (5)
|
Peer-Review Report-180K (62)
|
Answering Reviewers-74K (68)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (13)
|
Total Visits (6065)
|
Similar Articles (334)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (539)
|
Core Tip (478)
|
Article Highlights (510)
|
Full Article (HTML) (1964)
|
Figures (1-4) (344)
|
Tables (1-3) (330)
|
Full Article (PDF)-1672K (116)
|
Full Article with Cover (PDF)-12418K (110)
|
Full Article (XML)-173K (65)
|
Audio-467K (6)
|
Peer-Review Report-182K (59)
|
Answering Reviewers-71K (87)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5998)
|
Similar Articles (1985)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes

World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (515)
|
Core Tip (522)
|
Article Highlights (604)
|
Full Article (HTML) (1806)
|
Figures (1-3) (390)
|
Tables (1-2) (356)
|
Full Article (PDF)-1874K (107)
|
Full Article with Cover (PDF)-12619K (103)
|
Full Article (XML)-114K (62)
|
Audio-386K (11)
|
Peer-Review Report-233K (81)
|
Answering Reviewers-161K (73)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6825)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication

World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (448)
|
Core Tip (442)
|
Article Highlights (505)
|
Full Article (HTML) (1273)
|
Figures (1-4) (322)
|
Full Article (PDF)-5746K (106)
|
Full Article with Cover (PDF)-16492K (88)
|
Full Article (XML)-96K (70)
|
Audio-3997K (6)
|
Peer-Review Report-192K (62)
|
Answering Reviewers-146K (68)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4587)
|
Similar Articles (41)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease

World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (497)
|
Core Tip (471)
|
Article Highlights (511)
|
Full Article (HTML) (2231)
|
Figures (1-4) (311)
|
Tables (1-5) (341)
|
Full Article (PDF)-6006K (139)
|
Full Article with Cover (PDF)-16750K (104)
|
Full Article (XML)-200K (65)
|
Audio-376K (3)
|
Peer-Review Report-182K (74)
|
Answering Reviewers-60K (78)
|
Supplementary Material-355K (82)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7434)
|
Similar Articles (1839)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis

World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (452)
|
Core Tip (517)
|
Article Highlights (521)
|
Full Article (HTML) (1478)
|
Figures (1-4) (337)
|
Tables (1-4) (332)
|
Full Article (PDF)-5941K (108)
|
Full Article with Cover (PDF)-16687K (87)
|
Full Article (XML)-115K (65)
|
Audio-187K (9)
|
Peer-Review Report-215K (58)
|
Answering Reviewers-37K (73)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6034)
|
Similar Articles (2445)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (477)
|
Core Tip (482)
|
Full Article (HTML) (1185)
|
Figures (1-1) (404)
|
Full Article (PDF)-5068K (99)
|
Full Article with Cover (PDF)-15813K (86)
|
Full Article (XML)-63K (59)
|
Audio-811K (3)
|
Peer-Review Report-266K (72)
|
Answering Reviewers-225K (75)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4791)
|
Similar Articles (4201)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients

World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (462)
|
Core Tip (482)
|
Full Article (HTML) (1203)
|
Full Article (PDF)-325K (97)
|
Full Article with Cover (PDF)-11079K (78)
|
Full Article (XML)-24K (73)
|
Audio-243K (1)
|
Peer-Review Report-215K (53)
|
Answering Reviewers-19K (55)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3404)
|
Similar Articles (393)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open